User profiles for Sam O. Kleeman

Sam Kleeman

Cold Spring Harbor Laboratory
Verified email at cshl.edu
Cited by 275

Ketogenic diet promotes tumor ferroptosis but induces relative corticosterone deficiency that accelerates cachexia

M Ferrer, N Mourikis, EE Davidson, SO Kleeman… - Cell Metabolism, 2023 - cell.com
Glucose dependency of cancer cells can be targeted with a high-fat, low-carbohydrate
ketogenic diet (KD). However, in IL-6-producing cancers, suppression of the hepatic ketogenic …

Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial

…, N Jordan-Martin, BR Demestichas, SO Kleeman… - Gut, 2022 - gut.bmj.com
Objective We assessed whether famotidine improved inflammation and symptomatic
recovery in outpatients with mild to moderate COVID-19. Design Randomised, double-blind, …

Exploiting differential Wnt target gene expression to generate a molecular biomarker for colorectal cancer stratification

SO Kleeman, VH Koelzer, HJS Jones, EG Vazquez… - Gut, 2020 - gut.bmj.com
Objective Pathological Wnt pathway activation is a conserved hallmark of colorectal cancer.
Wnt-activating mutations can be divided into: i) ligand-independent (LI) alterations in …

[HTML][HTML] Not all Wnt activation is equal: ligand-dependent versus ligand-independent Wnt activation in colorectal cancer

SO Kleeman, SJ Leedham - Cancers, 2020 - mdpi.com
Simple Summary Colorectal cancer is the third most common cause of cancer-related
deaths. The Wnt signaling pathway is activated by genetic mutations in most patients with …

[HTML][HTML] Shared genetic susceptibility between trigger finger and carpal tunnel syndrome: a genome-wide association study

B Patel, SO Kleeman, D Neavin, J Powell… - The Lancet …, 2022 - thelancet.com
Background Trigger finger and carpal tunnel syndrome are the two most common non-traumatic
connective tissue disorders of the hand. Both of these conditions frequently co-occur, …

Radiomics for Renal Cell Carcinoma: Predicting Outcomes from Immunotherapy and Targeted Therapies—A Narrative Review

KS Rallis, SO Kleeman, M Grant, KL Ordidge… - European Urology …, 2021 - Elsevier
T-cell immunotherapy and molecular targeted therapies have become standard-of-care
treatments for renal cell carcinoma (RCC). There is a need to develop robust biomarkers that …

[HTML][HTML] Early neutrophilia marked by aerobic glycolysis sustains host metabolism and delays cancer cachexia

M Petruzzelli, M Ferrer, MJ Schuijs, SO Kleeman… - Cancers, 2022 - mdpi.com
Simple Summary Patients with cancer suffer from systemic metabolic impairment during cancer
progression. An elevated neutrophil–lymphocyte ratio is a negative predictor of outcome. …

Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer

…, Y Yatabe, D Shida, R Hamamoto, SO Kleeman… - British Journal of …, 2022 - nature.com
Background RSPO fusions that lead to WNT pathway activation are potential therapeutic
targets in colorectal cancer (CRC), but their clinicopathological significance remains unclear. …

[PDF][PDF] Cystatin C is glucocorticoid responsive, directs recruitment of Trem2+ macrophages, and predicts failure of cancer immunotherapy

SO Kleeman, TM Thakir, B Demestichas, N Mourikis… - Cell Genomics, 2023 - cell.com
Cystatin C (CyC), a secreted cysteine protease inhibitor, has unclear biological functions.
Many patients exhibit elevated plasma CyC levels, particularly during glucocorticoid (GC) …

[PDF][PDF] Cystatin C is associated with adverse COVID-19 outcomes in diverse populations

SO Kleeman, M Cordioli, PRHJ Timmers, A Khan… - Iscience, 2022 - cell.com
COVID-19 has highly variable clinical courses. The search for prognostic host factors for
COVID-19 outcome is a priority. We performed logistic regression for ICU admission against a …